pre-clinical
Make cost-effective decisions on pre-clinical advancement using DARC
1
DARC provides insights into your asset’s mechanism of action and dose-response relationship, as well as helps optimise drug delivery methods
DARC is fully translatable to clinical trials — we can help bridge the cellular signal into humans to de-risk translation
2
DARC helps evaluate the efficacy of your ophthalmic drug at the cellular level, in a range of in vitro and in vivo retinal disease models, allowing you to make informed go/no-go decisions.
3
TESTIMONIALS
Maximise trial success
Our specialist DARC team can determine the efficacy of your early-stage therapeutics
interested?
Book a MEETING WITH OUR EXPERTS TODAY
Dr. Alex Wilson,
Director of Corporate
Development & Quality
our publications
See below a sample of our research papers, click to read